{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:25:33Z","timestamp":1783488333435,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04360-2","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T16:06:08Z","timestamp":1753373168000},"page":"709-718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mediterranean diet, selenium and Graves\u2019 ophthalmopathy: a prospective, randomized, single-center study"],"prefix":"10.1007","volume":"90","author":[{"given":"R.","family":"Le Moli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Piticchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pallotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Geraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tumminia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Scuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Di Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Patern\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Belfiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Frasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"4360_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"L. Bartalena, G.J. Kahaly, L. Baldeschi, C.M. Dayan, A. Eckstein, C. Marcocci et al., The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur. J. Endocrinol. 185, 43\u201367 (2021). https:\/\/doi.org\/10.1530\/EJE-21-0479.","journal-title":"Eur. J. Endocrinol."},{"key":"4360_CR2","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1210\/clinem\/dgaa646","volume":"105","author":"GJ Kahaly","year":"2020","unstructured":"G.J. Kahaly, Management of Graves thyroidal and extrathyroidal disease: an update. J. Clin. Endocrinol. Metab. 105, 3704\u20133720 (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa646.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4360_CR3","doi-asserted-by":"publisher","first-page":"bqab188","DOI":"10.1210\/endocr\/bqab188","volume":"162","author":"L Zhang","year":"2021","unstructured":"L. Zhang, P. Rai, S. Miwa, M.S. Draman, D.A. Rees, A.S. Haridas et al., The role of mitochondria-linked fatty-acid uptake-driven adipogenesis in Graves orbitopathy. Endocrinology 162, bqab188 (2021). https:\/\/doi.org\/10.1210\/endocr\/bqab188.","journal-title":"Endocrinology"},{"key":"4360_CR4","doi-asserted-by":"publisher","first-page":"959276","DOI":"10.3389\/fendo.2022.959276","volume":"13","author":"R Le Moli","year":"2022","unstructured":"R. Le Moli, V. Vella, D. Tumino, T. Piticchio, A. Naselli, A. Belfiore et al., Inflammasome activation as a link between obesity and thyroid disorders: implications for an integrated clinical management. Front. Endocrinol. 13, 959276 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.959276.","journal-title":"Front. Endocrinol."},{"key":"4360_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.biopha.2018.09.058","volume":"108","author":"OM Ighodaro","year":"2018","unstructured":"O.M. Ighodaro, Molecular pathways associated with oxidative stress in diabetes mellitus. Biomed. Pharmacother. 108, 656\u2013662 (2018). https:\/\/doi.org\/10.1016\/j.biopha.2018.09.058.","journal-title":"Biomed. Pharmacother."},{"key":"4360_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1210\/jc.2013-1004","volume":"98","author":"TJ Smith","year":"2013","unstructured":"T.J. Smith, Is IGF-I receptor a target for autoantibody generation in Graves\u2019 disease?. J. Clin. Endocrinol. Metab. 98, 515\u2013518 (2013). https:\/\/doi.org\/10.1210\/jc.2013-1004.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4360_CR7","doi-asserted-by":"publisher","first-page":"3763565","DOI":"10.1155\/2018\/3763565","volume":"2018","author":"H Zheng","year":"2018","unstructured":"H. Zheng, J. Wei, L. Wang, Q. Wang, J. Zhao, S. Chen et al., Effects of selenium supplementation on Graves\u2019 disease: a systematic review and meta-analysis. Evid. Based Complement. Altern. Med. 2018, 3763565 (2018). https:\/\/doi.org\/10.1155\/2018\/3763565.","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"4360_CR8","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1089\/thy.2016.0256","volume":"26","author":"J Wichman","year":"2016","unstructured":"J. Wichman, K.H. Winther, S.J. Bonnema, L. Heged\u00fcs, Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: a systematic review and meta-analysis. Thyroid 26, 1681\u20131692 (2016). https:\/\/doi.org\/10.1089\/thy.2016.0256.","journal-title":"Thyroid"},{"key":"4360_CR9","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1210\/jc.2010-0191","volume":"95","author":"LH Duntas","year":"2010","unstructured":"L.H. Duntas, Selenium and the thyroid: a close-knit connection. J. Clin. Endocrinol. Metab. 95, 5180\u20135188 (2010). https:\/\/doi.org\/10.1210\/jc.2010-0191.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4360_CR10","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","volume":"364","author":"C Marcocci","year":"2011","unstructured":"C. Marcocci, G.J. Kahaly, G.E. Krassas, L. Bartalena, M. Prummel, M. Stahl et al., Selenium and the course of mild Graves\u2019 orbitopathy. N. Engl. J. Med. 364, 1920\u20131931 (2011). https:\/\/doi.org\/10.1056\/NEJMoa1012985.","journal-title":"N. Engl. J. Med."},{"key":"4360_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/nu17020363","volume":"20","author":"M Lagan\u00e0","year":"2025","unstructured":"M. Lagan\u00e0, T. Piticchio, A. Alibrandi, R. Le Moli, F. Pallotti, A. Campenn\u00ec et al., Effects of dietary habits on markers of oxidative stress in subjects with Hashimoto\u2019s thyroiditis: comparison between the mediterranean diet and a gluten-free diet. Nutrients 20, 363 (2025). https:\/\/doi.org\/10.3390\/nu17020363.","journal-title":"Nutrients"},{"issue":"19","key":"4360_CR12","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.3390\/nu16193397","volume":"16","author":"V Oteri","year":"2024","unstructured":"V. Oteri, F. Galeano, S. Panebianco, T. Piticchio, R. Le Moli, L. Frittitta et al., Influence of mediterranean diet on sexual function in people with metabolic syndrome: a narrative review. Nutrients 16(19), 3397 (2024). https:\/\/doi.org\/10.3390\/nu16193397.","journal-title":"Nutrients"},{"key":"4360_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1401155","volume":"15","author":"R Le Moli","year":"2024","unstructured":"R. Le Moli, A. Naselli, G. Costanzo, T. Piticchio, D. Tumino, G. Pellegriti et al., Determinants of clinical outcome in patients with moderate\/severe Graves\u2019 orbitopathy undergoing treatment with parenteral glucocorticoids: a retrospective study. Front. Endocrinol. 15, 1401155 (2024). https:\/\/doi.org\/10.3389\/fendo.2024.1401155.","journal-title":"Front. Endocrinol."},{"key":"4360_CR14","unstructured":"ARPA Sicilia, Annuario Regionale Dei Dati Ambientali 25 (2011)."},{"key":"4360_CR15","unstructured":"LARN, Livelli di assunzione di riferimento di nutrienti ed energia per la popolazione Italiana. SINU V revisione. 250 (2014)."},{"key":"4360_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/00131640121971419","volume":"61","author":"JL Mendoza","year":"2001","unstructured":"J.L. Mendoza, K.L. Stafford, Confidence intervals, power calcu- lation, and sample size estimation for the squared multiple cor- relation coefficient under the fixed and random regression models: a computer program and useful standard tables. Educ. Psychol. Meas. 61, 650\u2013667 (2001). https:\/\/doi.org\/10.1177\/00131640121971419.","journal-title":"Educ. Psychol. Meas."},{"key":"4360_CR17","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1210\/jc.2012-3873","volume":"98","author":"ML Tanda","year":"2013","unstructured":"M.L. Tanda, E. Piantanida, L. Liparulo, G. Veronesi, A. Lai, L. Sassi et al., Prevalence and natural history of Graves\u2019 orbitopathy in a large series of patients with newly diagnosed Graves\u2019 hyperthyroidism seen at a single center. J. Clin. Endocrinol. Metab. 98, 1443\u20131449 (2013). https:\/\/doi.org\/10.1210\/jc.2012-3873.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4360_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.608428","volume":"11","author":"G Lanzolla","year":"2021","unstructured":"G. Lanzolla, M. Marin\u00f2, C. Marcocci, Selenium in the treatment of Graves\u2019 hyperthyroidism and eye disease. Front. Endocrinol. 11, 608428 (2021). https:\/\/doi.org\/10.3389\/fendo.2020.608428.","journal-title":"Front. Endocrinol."},{"key":"4360_CR19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1089\/thy.2020.0299","volume":"31","author":"RM Ruggeri","year":"2021","unstructured":"R.M. Ruggeri, S. Giovinazzo, M.C. Barbalace et al., Influence of dietary habits on oxidative stress markers in Hashimoto\u2019s thyroiditis. Thyroid 31, 709 (2021). https:\/\/doi.org\/10.1089\/thy.2020.0299.","journal-title":"Thyroid"},{"key":"4360_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nutres.2023.12.002","volume":"122","author":"T Urbano","year":"2024","unstructured":"T. Urbano, T. Filippini, M. Malavolti, S. Fustinoni, B. Michalke, L.A. Wise et al., Adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet and exposure to selenium species: a cross-sectional study. Nutr. Res. 122, 44\u201354 (2024). https:\/\/doi.org\/10.1016\/j.nutres.2023.12.002.","journal-title":"Nutr. Res."},{"key":"4360_CR21","doi-asserted-by":"publisher","first-page":"11628","DOI":"10.3390\/ijms252111628","volume":"25","author":"M Kulbay","year":"2024","unstructured":"M. Kulbay, S.M. Tanya, N. Tuli, J. Dahoud, A. Dahoud, F. Alsaleh et al., A comprehensive review of thyroid eye disease pathogenesis: from immune dysregulations to novel diagnostic and therapeutic approaches. Int. J. Mol. Sci. 25, 11628 (2024). https:\/\/doi.org\/10.3390\/ijms252111628.","journal-title":"Int. J. Mol. Sci."},{"key":"4360_CR22","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.2147\/OPTH.S456543","volume":"18","author":"A Kozaki","year":"2024","unstructured":"A. Kozaki, R. Inoue, N. Yaji, K. Nishiyama, T. Inoue, Subcutaneous injections of triamcinolone acetonide for upper eyelid retraction and swelling associated with thyroid eye disease: a retrospective case series study. Clin. Ophthalmol. 18, 2147\u20132154 (2024). https:\/\/doi.org\/10.2147\/OPTH.S456543.","journal-title":"Clin. Ophthalmol."},{"key":"4360_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2265.2008.03192.x","volume":"69","author":"XG Vos","year":"2008","unstructured":"X.G. Vos, N. Smit, E. Endert, J.G. Tijssen, W.M. Wiersinga, Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves\u2019 hyperthyroidism: a prospective study. Clin. Endocrinol. 69, 311\u2013317 (2008). https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03192.x.","journal-title":"Clin. Endocrinol."},{"key":"4360_CR24","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1210\/jc.2005-2813","volume":"91","author":"AK Eckstein","year":"2006","unstructured":"A.K. Eckstein, M. Plicht, H. Lax, Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease. J. Clin. Endocrinol. Metab. 91, 3464\u20133470 (2006). https:\/\/doi.org\/10.1210\/jc.2005-2813.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4360_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.5937\/jomb0-34718","volume":"41","author":"M Sari\u0107-Matutinovi\u0107","year":"2022","unstructured":"M. Sari\u0107-Matutinovi\u0107, T. Diana, B. Nedeljkovi\u0107-Beleslin, J. \u0106iri\u0107, M. \u017darkovi\u0107, I. Perovi\u0107-Blagojevi\u0107 et al., Sensitivity of three thyrotropin receptor antibody assays in thyroid-associated orbitopathy. J. Med. Biochem. 41, 211\u2013220 (2022). https:\/\/doi.org\/10.5937\/jomb0-34718.","journal-title":"J. Med. Biochem."},{"key":"4360_CR26","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s40618-023-02085-5","volume":"46","author":"M Sari\u0107 Matutinovi\u0107","year":"2023","unstructured":"M. Sari\u0107 Matutinovi\u0107, G.J. Kahaly, M. \u017darkovi\u0107, The phenotype of Graves\u2019 orbitopathy is associated with thyrotropin receptor antibody levels. J. Endocrinol. Invest. 46, 2309\u20132317 (2023). https:\/\/doi.org\/10.1007\/s40618-023-02085-5.","journal-title":"J. Endocrinol. Invest."},{"key":"4360_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.coemr.2018.01.007","volume":"2","author":"CC Krieger","year":"2018","unstructured":"C.C. Krieger, S.J. Morgan, S. Neumann, M.C. Gershengorn, Thyroid stimulating hormone (TSH)\/insulin-like growth factor 1 (IGF1) receptor cross-talk in human cells. Curr. Opin. Endocr. Metab. Res. 2, 29\u201333 (2018). https:\/\/doi.org\/10.1016\/j.coemr.2018.01.007.","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"4360_CR28","doi-asserted-by":"publisher","first-page":"e12328","DOI":"10.1111\/cob.12328","volume":"9","author":"A Kyriacou","year":"2019","unstructured":"A. Kyriacou, A. Kyriacou, K.C. Makris, A.A. Syed, P. Perros, Weight gain following treatment of hyperthyroidism\u2013a forgotten tale. Clin. Obes. 9, e12328 (2019). https:\/\/doi.org\/10.1111\/cob.12328.","journal-title":"Clin. Obes."},{"key":"4360_CR29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000512078","volume":"10","author":"J Karmisholt","year":"2021","unstructured":"J. Karmisholt, A. Carl\u00e9, S. Andersen, Body weight changes in hyperthyroidism: timing and possible explanations during a one year repeated measurement study. Eur. Thyroid. J. 10, 208\u2013214 (2021). https:\/\/doi.org\/10.1159\/000512078.","journal-title":"Eur. Thyroid. J."},{"key":"4360_CR30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1530\/EJE-21-0366","volume":"185","author":"L Sun","year":"2021","unstructured":"L. Sun, H.J. Goh, S. Verma, P. Govindharajulu, S.A. Sadananthan, N. Michael et al., Metabolic effects of brown fat in transitioning from hyperthyroidism to euthyroidism. Eur. J. Endocrinol. 185, 553\u2013563 (2021). https:\/\/doi.org\/10.1530\/EJE-21-0366.","journal-title":"Eur. J. Endocrinol."},{"key":"4360_CR31","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1089\/thy.2000.10.1107","volume":"10","author":"S Tigas","year":"2000","unstructured":"S. Tigas, J. Idiculla, G. Beckett, A. Toft, Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy?. Thyroid 10, 1107\u20131111 (2000). https:\/\/doi.org\/10.1089\/thy.2000.10.1107.","journal-title":"Thyroid"},{"key":"4360_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12328","volume":"9","author":"A Kyriacou","year":"2019","unstructured":"A. Kyriacou, A. Kyriacou, K.C. Makris, A.A. Syed, P. Perros, Weight gain following treatment of hyperthyroidism-A forgotten tale. Clin. Obes. 9, e12328 (2019). https:\/\/doi.org\/10.1111\/cob.12328.","journal-title":"Clin. Obes."},{"key":"4360_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09471","volume":"8","author":"T Yotsapon","year":"2022","unstructured":"T. Yotsapon, C. Waralee, P. Hussamon, S. Panita, B. Siriwan, N. Soontaree, W. Ekgaluck, R. Rajata, H. Thep, Duration of antithyroid drug treatment may predict weight gain after radioactive iodine therapy in patients with Graves\u2019 disease. Heliyon 8, e09471 (2022). https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09471.","journal-title":"Heliyon"},{"key":"4360_CR34","doi-asserted-by":"publisher","first-page":"8894792","DOI":"10.1155\/2020\/8894792","volume":"2020","author":"A Baranowska-Bik","year":"2020","unstructured":"A. Baranowska-Bik, W. Bik, The association of obesity with autoimmune thyroiditis and thyroid function-possible mechanisms of bilateral interaction. Int J. Endocrinol. 2020, 8894792 (2020). https:\/\/doi.org\/10.1155\/2020\/8894792.","journal-title":"Int J. Endocrinol."},{"key":"4360_CR35","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1089\/thy.2018.0731","volume":"29","author":"B Torlinska","year":"2019","unstructured":"B. Torlinska, L. Nichols, M.A. Mohammed, C. McCabe, K. Boelaert, Patients treated for hyperthyroidism are at increased risk of becoming obese: findings from a large prospective secondary care cohort. Thyroid 29, 1380\u20131389 (2019). https:\/\/doi.org\/10.1089\/thy.2018.0731.","journal-title":"Thyroid"},{"key":"4360_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.numecd.2015.01.003","volume":"25","author":"R Le Moli","year":"2015","unstructured":"R. Le Moli, V. Muscia, A. Tumminia, L. Frittitta, M. Buscema, F. Palermo et al., Type 2 diabetic patients with Graves\u2019 disease have more frequent and severe Graves\u2019 orbitopathy. Nutr. Metab. Cardiovasc. Dis. 25, 452\u2013457 (2015). https:\/\/doi.org\/10.1016\/j.numecd.2015.01.003.","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"4360_CR37","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1089\/thy.2017.0430","volume":"28","author":"E Sabini","year":"2018","unstructured":"E. Sabini, B. Mazzi, M.A. Profilo, T. Mautone, G. Casini, R. Rocchi et al., High serum cholesterol is a novel risk factor for Graves\u2019 orbitopathy: results of a cross-sectional study. Thyroid 28, 386\u2013394 (2018). https:\/\/doi.org\/10.1089\/thy.2017.0430.","journal-title":"Thyroid"},{"key":"4360_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.609895","volume":"22","author":"A Naselli","year":"2020","unstructured":"A. Naselli, D. Moretti, C. Regalbuto, M.L. Arpi, F. Lo Giudice, F. Frasca et al., Evidence that baseline levels of low-density lipoproteins cholesterol affect the clinical response of Graves\u2019 ophthalmopathy to parenteral corticosteroids. Front. Endocrinol. 22, 609895 (2020). https:\/\/doi.org\/10.3389\/fendo.2020.609895.","journal-title":"Front. Endocrinol."},{"key":"4360_CR39","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1507\/endocrj.EJ20-0062","volume":"67","author":"C Pace","year":"2020","unstructured":"C. Pace, D. Tumino, M. Russo, R. Le Moli, A. Naselli, G. Borz\u00ec et al., Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression. Endocr. J. 67, 1093\u20131098 (2020). https:\/\/doi.org\/10.1507\/endocrj.EJ20-0062.","journal-title":"Endocr. J."},{"key":"4360_CR40","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.3390\/nu15183953","volume":"15","author":"RM Ruggeri","year":"2023","unstructured":"R.M. Ruggeri, M.C. Barbalace, L. Croce, M. Malaguti, A. Campenn\u00ec, M. Rotondi et al., Autoimmune thyroid disorders: the mediterranean diet as a protective choice. Nutrients 15, 3953 (2023). https:\/\/doi.org\/10.3390\/nu15183953.","journal-title":"Nutrients"},{"key":"4360_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.scitotenv.2007.01.066","volume":"376","author":"M Spadoni","year":"2007","unstructured":"M. Spadoni, M. Voltaggio, M. Carcea, E. Coni, A. Raggi, F. Cubadda, Bioaccessible selenium in Italian agricultural soils: comparison of the biogeochemical approach with a regression model based on geochemical and pedoclimatic variables. Sci. Total. Env. 376, 160\u2013177 (2007). https:\/\/doi.org\/10.1016\/j.scitotenv.2007.01.066.","journal-title":"Sci. Total. Env."},{"key":"4360_CR42","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1210\/clinem\/dgad030","volume":"108","author":"F Biscarini","year":"2023","unstructured":"F. Biscarini, G. Masetti, I. Muller, H.L. Verhasselt, D. Covelli, G. Colucci et al., Gut microbiome associated with graves disease and graves orbitopathy: The INDIGO Multicenter European Study. J. Clin. Endocrinol. Metab. 108, 2065\u20132077 (2023). https:\/\/doi.org\/10.1210\/clinem\/dgad030.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4360_CR43","doi-asserted-by":"publisher","first-page":"13450","DOI":"10.3390\/ijms232113450","volume":"23","author":"N Sawicka-Gutaj","year":"2022","unstructured":"N. Sawicka-Gutaj, D. Gruszczy\u0144ski, N. Zawalna, K. Nijakowski, I. Muller, T. Karpi\u0144ski, M. Salvi, M. Rucha\u0142a, Microbiota alterations in patients with autoimmune thyroid diseases: a systematic review. Int. J. Mol. Sci. 23, 13450 (2022). https:\/\/doi.org\/10.3390\/ijms232113450.","journal-title":"Int. J. Mol. Sci."}],"updated-by":[{"DOI":"10.1007\/s12020-025-04386-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000}}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04360-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04360-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04360-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:09:28Z","timestamp":1761736168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04360-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4360"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04360-2","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12020-025-04386-6","URL":"https:\/\/doi.org\/10.1007\/s12020-025-04386-6","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}